Pharmaceuticals sector

‘Store looked almost identical’: Malaysian pharmacies warn of impersonators selling fake products

Pharmacies notice some counterfeits were priced 30 to 40 per cent cheaper than genuine products.

Ozempic-maker sees Singapore as a platform to pilot treatments for diabetes, obesity

Novo Nordisk will capitalise on Singapore’s strengths in digital healthcare to ramp up its innovations in diabetes and obesity treatment, said Novo Nordisk’s senior vice-president for Asia-Pacific Jay Thyagarajan.

Pharma giant drops supplier after AFP deforestation investigation

Haleon – known for household brands such as Panadol, Sensodyne and Centrum vitamins – said it was "very concerned"..

China’s pharma dominance is just beginning

China is also making inroads in frontier biotechnology.

US removes ‘inaccurate statement’ on Singapore trade surplus; Govt to attend hearings on probes

The temporary global 10 per cent tariff rate imposed under Section 122 - announced after the court ruling - expires in July.

Pharmaceutical logistics in demand as war rattles supply chains

Germany’s DHL has a health logistics campus near Frankfurt, dedicated to ensuring drugs and other crucial medical products reliably get to where they’re needed.

BioNTech to wind up Singapore vaccine manufacturing plant by early 2027

In 2022, BioNTech cited Singapore’s excellent business climate and rich talent among reasons why it plans to make Singapore its regional headquarters in South-east Asia.

US FDA approves new insulin injection for Type 2 diabetes

Novo Nordisk's new product reduces injections from seven to one a week.

India to tackle global obesity with cheap, Ozempic knock-off jabs

Semaglutide is the active ingredient in weight-loss drugs such as Ozempic and Wegovy.

News analysis

Middle East war disrupts pharma air routes, threatening cancer and other drugs’ supply

A photograph shows Doha's skyline on March 10, 2026. The oil-rich Gulf has borne the brunt of Iran's attacks in response to US-Israeli strikes that sparked the Middle East war, with Tehran targeting US assets but also civilian infrastructure, including energy facilities and airports. (Photo by AFP) / Attention editors: AFP covers the war in the Middle East through its extensive regional network, including bureaus in Tehran, Jerusalem, and several neighboring countries. Since the start of the conflict, journalists have been working under increasingly restrictive conditions. Authorities in several countries have limited reporters' movements, photo and live video coverage from sensitive locations. Some governments and armed groups have banned images of missile or drone strikes and other security-related sites. /

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.